An Examination of the Application of Cannabis in Therapeutic Use for Parkinson's syndrome
Open Access
- 9 August 2025
- journal article
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 772
Abstract
The consequences of cannabis usage on Multiple Sclerosis (MS) and Parkinson's disease (PD) are still substantially uncertain despite recognizing that Cannabis was used for thousands of years as a medication. The evaluation of cannabis usage PD and MS, and a comparison of cannabis users' and non-users' self-reported assessments of neurological impairment were primary goals of this research. The survey contained standardized questions to collect information on demographics and Cannabis use questionnaires to evaluate participants' physical activity levels, neurological function, and weariness. Linear regression, Hierarchical Regression, and ANCOVA analysis of variance were employed in research. Were 900 respondents in a final data set. Cannabis consumers today were younger and less inclined to be considered fat. Regarding Emotional Variability, Cognitive Function, and Fatigue, cannabis users reported decreased degrees of disability. Cannabis may benefit PD and MS patients' Emotional Variability, Cognitive Function, Fatigue, and Physiological Weight. PD and MS patients' cannabis use: long-term advantages and downsides, and determining if these relationships are causal, more research is required to utilize longitudinally and clinically measured assessments among these domains.Keywords
This publication has 27 references indexed in Scilit:
- The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's diseaseContemporary Clinical Trials Communications, 2023
- Automated restricted Boltzmann machine classifier for early diagnosis of Parkinson’s disease using digitized spiral drawingsJournal of Ambient Intelligence and Humanized Computing, 2022
- Cannabidiol Alleviates the Damage to Dopaminergic Neurons in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson’s Disease Mice Via Regulating Neuronal Apoptosis and NeuroinflammationNeuroscience, 2022
- Cannabis: Chemistry, extraction and therapeutic applicationsChemosphere, 2022
- Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and CannabisNeurotherapeutics, 2020
- Medical cannabis as an alternative therapeutics for Parkinsons’ disease: Systematic reviewComplementary Therapies in Clinical Practice, 2020
- Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's diseaseNeuropharmacology, 2020
- Evidence for the use of cannabinoids in Parkinson’s diseaseJournal of Neural Transmission, 2019
- Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?European Archives of Psychiatry and Clinical Neuroscience, 2019
- Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based investigationComplementary Therapies in Medicine, 2017